Radiation Therapy for Skin Cancer
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.251 alerts
Get alerted when Policy CP.MP.251 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity criteria and coding implications for use of radiation therapy (definitive and adjuvant) in treating non-melanoma skin cancers, Merkel cell carcinoma, and cutaneous melanoma for members of Centene-affiliated health plans (Arizona Complete Health).
No material clinical or coverage changes in this revision.
Medical Necessity and Coverage Criteria
Medical necessity criteria by cancer type and treatment intent
Medically necessary when specified criteria are met for each cancer type and treatment intent.
[[chunk 2]]
[[chunk 2]]
[[chunk 2]]
[[chunk 3]]
[[chunk 3]]
[[chunk 4]]
[[chunk 4]]
[[chunk 2],[chunk 4]]
[[chunk 4]]
Electronic surface brachytherapy and image guided superficial radiation therapy (IGSRT) are considered not medically necessary for the treatment of any skin cancer due to insufficient data on long-term safety and efficacy.
Definitive radiation therapy is not recommended for members with genetic conditions that confer heightened radiosensitivity, for example ataxia telangiectasia, nevoid basal cell carcinoma syndrome (Gorlin syndrome), or Li‑Fraumeni syndrome.
Radiation therapy is not routinely repeated for recurrent disease occurring in a field that has previously received radiation.
Coverage of radiation therapy is subject to the terms, conditions, exclusions and limitations of the member’s coverage documents and applicable state and federal requirements; this policy does not guarantee payment or constitute a contract or promise of benefits.
Coding and Clinical Thresholds
| 77261 | Therapeutic radiology treatment planning; simple. |
| 77262 | Therapeutic radiology treatment planning; intermediate. |
| 77263 | Therapeutic radiology treatment planning; complex. |
| 77280 | Therapeutic radiology simulation-aided field setting; simple. |
| 77285 | Therapeutic radiology simulation-aided field setting; intermediate. |
| 77290 | Therapeutic radiology simulation-aided field setting; complex. |
| 77295 | 3-dimensional radiotherapy plan, including dose-volume histograms. |
| 77300 | Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician. |
| 77301 | Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications. |
| 77316 | Brachytherapy isodose plan; simple (calculation[s] made from 1 to 4 sources, or remote afterloading brachytherapy, 1 channel), includes basic dosimetry calculation(s). |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields. |
| G6003-G6014 | Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 MeV [to 20 MeV or greater]. |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session. |
| G6016 | Compensator-based beam modulation treatment delivery of inverse planned treatment using three or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session. |
Provider Requirements and Prior Authorization
Prior Authorization Required for Radiation Planning and Delivery
Prior authorization is required for radiation therapy planning and delivery codes. Providers must submit supporting clinical records (treatment planning documents, dosimetry, simulation notes, and justification for modality) to demonstrate that medical necessity criteria are met for the specific cancer type and treatment intent.
Coverage Decisions and Administration of Benefits
Coverage decisions and the administration of benefits are governed by this clinical policy together with the member's coverage documents and applicable legal/regulatory requirements. This policy is a guide to medical necessity and does not guarantee payment or coverage. Providers should verify contract terms and plan-level procedures when submitting prior authorizations and claims.
- Coverage decisions are subject to the terms, conditions, exclusions and limitations of the member's evidence of coverage, certificate of coverage, policy, or contract.
- State Medicaid provisions take precedence over this policy when conflicts exist; Medicare NCDs/LCDs and CMS guidance should be reviewed for Medicare members.
Documentation and Contractual Obligations
Providers must follow standard documentation and contractual requirements when requesting services. Documentation submitted must support that the medical necessity criteria in this policy are satisfied for the specific diagnosis and treatment intent (definitive, adjuvant, or palliative).
- Required documentation includes: clinical notes, pathology reports, imaging studies, surgical consults or records (if applicable), treatment planning records, and rationale if surgery was not performed or was declined.
- Providers are expected to comply with their contractual obligations and any Health Plan-level administrative policies and procedures; this clinical policy does not replace contractual rules.
Surgery Preferred Prior to Radiation When Feasible
When clinically feasible, surgical excision is the preferred primary treatment for skin cancers. Radiation therapy is indicated when the member is not a surgical candidate, declines surgery, surgery would compromise function or cosmesis, resection is not feasible for adjuvant reasons, or other policy-specified criteria are met.
- Document why surgery is not performed (e.g., patient refusal, medical comorbidity, anticipated unacceptable functional/cosmetic outcome).
- For recurrent disease in a previously irradiated field, radiation is generally not routinely repeated unless supported by clinical rationale and documentation.
Not Medically Necessary Procedures
Electronic surface brachytherapy and image-guided superficial radiation therapy (IGSRT) are considered not medically necessary for treatment of any skin cancer due to insufficient evidence on long-term safety and efficacy. Authorization requests for these modalities may be denied.
- Examples of not medically necessary procedures: Electronic surface brachytherapy; IGSRT.
Provider Responsibilities and Coding
Providers are expected to submit complete and accurate supporting records with prior authorization requests and to follow coding guidance. Inclusion or omission of CPT/HCPCS codes in this policy is informational and does not guarantee coverage; verify coding and billing with current professional resources before claim submission.
- Reference up-to-date coding sources for CPT and HCPCS codes related to treatment planning, simulation, dosimetry, brachytherapy, and treatment delivery (see coding implications section).
- Providers are independent contractors and remain responsible for clinical decision-making and documentation.
Background and Scope
Surgical excision is the primary standard treatment for most skin cancers. Radiation therapy serves as an important definitive or adjuvant modality when surgery is not feasible, is declined by the member, or would substantially compromise function or cosmesis. For example, radiation may be used definitively in medically inoperable melanoma in situ or lentigo maligna, or as adjuvant therapy for high‑risk resected regional disease across skin cancer types.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.